Detalhe da pesquisa
1.
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study.
Eur J Nucl Med Mol Imaging
; 47(10): 2372-2382, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32123969
2.
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors.
Eur J Nucl Med Mol Imaging
; 42(1): 5-19, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25273832
3.
Yttrium-labelled peptides for therapy of NET.
Eur J Nucl Med Mol Imaging
; 39 Suppl 1: S93-102, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22388625
4.
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors.
JAMA Netw Open
; 5(2): e220290, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201309
5.
Peptide receptor radionuclide therapy with ¹77Lu-DOTATATE: the IEO phase I-II study.
Eur J Nucl Med Mol Imaging
; 38(12): 2125-35, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21892623
6.
First Ex Vivo Results of ß--Radioguided Surgery in Small Intestine Neuroendocrine Tumors with 90Y-DOTATOC.
Cancer Biother Radiopharm
; 36(5): 397-406, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33601932
7.
18F-FDG PET/CT in asymptomatic patients with COVID-19: the submerged iceberg surfaces.
Jpn J Radiol
; 38(11): 1007-1011, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577869
8.
State of the Art and Recent Developments of Radiopharmaceuticals for Pancreatic Neuroendocrine Tumors Imaging.
Curr Radiopharm
; 12(2): 107-125, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30843499
9.
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas.
Br J Haematol
; 139(4): 590-9, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17979944
10.
Cerenkov and radioluminescence imaging of brain tumor specimens during neurosurgery.
J Biomed Opt
; 21(5): 50502, 2016 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27156713
11.
PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Ecancermedicalscience
; 10: 629, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27110285
12.
Toward radioguided surgery with ß- decays: uptake of a somatostatin analogue, DOTATOC, in meningioma and high-grade glioma.
J Nucl Med
; 56(1): 3-8, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25500828
13.
Peptide receptor radionuclide therapy for advanced neuroendocrine tumors.
Thorac Surg Clin
; 24(3): 333-49, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25065935
14.
PET/CT characterization of non-small-cell lung cancer heterogeneity.
Nucl Med Commun
; 36(5): 411-3, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25816217
15.
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.
Eur J Nucl Med Mol Imaging
; 35(10): 1847-56, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18427807
16.
Pretargeted antibody-guided radioimmunotherapy in a child affected by resistant anaplastic large cell lymphoma.
Eur J Haematol
; 79(3): 258-62, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17655697